期刊文献+

NF-κB在急性坏死性胰腺炎相关性肺损伤中的表达改变及乌斯他丁的治疗作用 被引量:2

Protective effect of ulinastatin on acute pancreatitis associated lung injuries in rats
原文传递
导出
摘要 目的:研究NF-κB在急性坏死性胰腺炎(ANP)相关性肺损伤中的表达改变情况及乌斯他丁的治疗作用机制。方法:采用逆行胰胆管牛磺胆酸钠(TAC)注射方法建立大鼠ANP肺损伤模型。SD大鼠分为假手术组(SO组),ANP生理盐水对照组(ANP组)和乌斯他丁治疗组。各组于术后3,6,12h剖杀,检验NF-κB的表达情况及肺组织髓过氧化物酶(MPO)活性和TNF-α的变化及肺组织的病理学改变。结果:相对于SO组,ANP组大鼠从3h开始,MPO及TNF-α增高,NF-κB表达于3h增高,6h达到高峰,给予乌斯他丁治疗后,肺损伤各指标均有不同程度降低(P<0.05),NF-κB表达明显降低(P<0.05)。结论:ANP相关肺损伤与NF-κB的激活有关,乌斯他丁通过下调NF-κB表达对ANP相关性肺损伤起保护作用。 Objective:To investigate the change of NF-κB expression and the protective effect of ulinastatin(UST)in acute lung injury of acute necrotizing pancreatitis(ANP).Method:Murine modle of ANP was established by retrograde injection of artificial bile into the biliopancreatic duct.The Sprague-Dawley were divided into sham operation group(SO group),ANP saline injection group(ANP group),and ANP UST treated group(UST group).Each group were sacrificed at 3,6,12 h after the operation to test the expression of NF-κB,myeloperoxidase(MPO)activity in lung tissue,the change of TNF-α,and the pathological changes of lung tissue.Result:Compared with sham operated group,TNF-a,MOP level of ANP group in lung tissie were increased from 3 h,and NF-κB was significantly increased at 3 h,peaking at 6 h.In contrast,TNF-αand MOP level were markedly decreased(P0.05)and the expression of NF-κB was inhibited(P0.05)after treated by UST.Conclusion:The expression of NF-κB is inceasd in lung in ANP,UST had an protective effect in lung injuries in ANP by down-regulating NF-κB.
作者 王威 王春友
出处 《临床急诊杂志》 CAS 2010年第4期234-236,共3页 Journal of Clinical Emergency
关键词 急性坏死性胰腺炎 肺损伤 NF-ΚB 乌斯他丁 pancreatitis acute necrotizing lung injury NF-κB UST
  • 相关文献

参考文献4

二级参考文献29

  • 1Jitsuo H, Yoshiumi K, Shuji I, et al. Therapeutic effects of continuous intraarterial antibiotic infusion in preventing pancreatic infection in experimental acute necrotizing pancreatitis. Pancreas,1996,13:184-192.
  • 2Tener S,Banks PA. Acute pancreatitis:non-surgical management. World J Surg,1997,21:143-148.
  • 3Edward L,BradleyⅢ.A clinically based classification system for acute pancreatitis[J].Arch Surg,1993,128:586-591.
  • 4American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference.Definition for sepsis and organ failure and guidelines for use of innovative therapies in sepsis[J].Chest,1992,60:H1790.
  • 5Knaus W A,Draper E A,Wagner D P,et al.APACHEⅡ:a severity of disease classification system[J].Crit Care Med,1985,13:818-829.
  • 6Avery B,Nathens S,John C,et al.Sepsis,SIRS,and MODS:what's in a name[J].World J Surg,1996,20:386-391.
  • 7Wrobleski D M,Barth M M,Oyen L J.Necrotizing pancreatitis:pathophysilogy,diagnosis,and acute care management[J].AACN Clin Issues,1999,10:464-477.
  • 8Ogawa M.Acute pancreatitis cytokines:"second attack" by septic complication leads to organ failure pancreas[J].Br J Surg,1998,16:312-313.
  • 9Hietaranta A,Kemppainen E,Puolakkainen P,et al.Extracellular phospholipases A2 in relation to systemic inflammatory response syndrome (SIRS) and systemic complications in severe acute pancreatitis[J].Pancreas,1999,18:385-391.
  • 10Takala A,Jousela I,Takkunen O,et al.Aprospective study of inflammation markers in patients at risk of indirect acute lung injury[J].Shock,2002,17:252-257.

共引文献118

同被引文献20

  • 1王要军,葛文松.TNF-α、IL-6、TAP与急性胰腺炎严重程度的相关性研究[J].中国误诊学杂志,2009,9(6):1261-1262. 被引量:26
  • 2黄亮,季宪飞.降钙素基因相关肽对内毒素急性肺损伤的保护作用[J].临床急诊杂志,2004,5(4):4-6. 被引量:4
  • 3TSUANG W, NAVANEETHAN U, RUIZ K, et al. Hypertriglyceridemic pancreatitis: presentation and management[J]. Am J Gastroenterol, 2009, 104: 914 -991.
  • 4EWALD N, HARDT P D, KLOER H U. Severe hy- pertriglyceridemia and pancreatitis: presentation and management[J]. Curr Opin Lipidol, 2009,20:497 - 504.
  • 5GUBENSEK J, BUTUROVIC-PONIKVAR J, MARN-PERNAT A, et al. Treatmert of hyperlipi- demic acute pancreatitis with plasma exchange:a sin- glecenter experience[J]. Ther Apher Dial, 2009, 13 : 314-317.
  • 6MARTIN D, MCCANN E, GLYNN P. Rheologic re- flection in hypertriglyceridemia-induced pancreatitis[J]. South Med J,2009,102:1049-1051.
  • 7Ware L B,Matthay M A.The acute respiratory distress syndrome[J].N Engl J Med,2000,342:1334-1349.
  • 8Song Z,Cui Y,Ding M Z,et al.Protective effects of recombinant human brain natriuretic peptide against LPS-Induced acute lung injury in dogs[J].Int Immunopharmacol,2013,17:508-512.
  • 9Briel M,Meade M,Mercat A,et al.Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome:systematic review and meta-analysis[J].JAMA,2010,303:865-873.
  • 10Towfigh S,Peralta M V,Martin M J,et al.Acute respiratory distress syndrome in non-trauma surgical patients:a 6-year study[J].J Trauma,2009,67:1239-1243.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部